Myelin is the multi-layered glial sheath around axons in the vertebrate nervous system. Myelinating glia develop and function in intimate association with neurons and neuron-glial interactions control much of the life history of these cells. However, many of the factors that regulate key aspects of myelin development and maintenance remain unknown. To discover new molecules that are important for glial development and myelination, we undertook a screen of zebrafish mutants with previously characterized neural defects. We screened for myelin basic protein (mbp) mRNA by in situ hybridization and identified four mutants (neckless, motionless, iguana and doc) that lacked mbp expression in parts of the peripheral and central nervous systems (PNS or CNS), despite the presence of axons. In all four mutants electron microscopy revealed that myelinforming glia were present and had formed loose wraps around axons but did not form compact myelin. We found that addition of exogenous retinoic acid (RA) rescued mbp expression in neckless mutant embryos, which lack endogenous RA synthesis. Timed application of the RA synthesis inhibitor DEAB to wild type embryos showed that RA signalling is required at least 48 h before the onset of myelin protein synthesis in both CNS and PNS.
Introduction
Myelin is a specialization of vertebrate nervous systems that enables rapid saltatory conduction of action potentials. Physically, it takes the form of a multi-layered glial sheath around axons. In the peripheral nervous system (PNS), it is produced by Schwann cells and in the central nervous system (CNS) by oligodendrocytes.
In all vertebrates that myelinate, including fish, Schwann cells develop from neural crest-derived precursors, which associate with and proliferate along axonal tracts that grow out from the neural tube and peripheral ganglia (reviewed in Jessen and Mirsky, 2005) . Schwann cell precursors extend processes that envelop axon bundles and progressively segregate and subdivide them. Ultimately, each myelinating Schwann cell ensheaths a single axonal segment, then elaborates a multilayered myelin sheath that gradually becomes compacted. In the CNS, oligodendrocyte progenitors (OLPs) are generated by neuroepithelial precursors in parts of the ventricular zone (VZ) of the embryonic neural tube. They proliferate and migrate widely from their sites of origin before associating with axons and differentiating into oligodendrocytes, which elaborate myelin sheaths round single or multiple axons. In the spinal cord, the great majority of OLPs are formed from a specialized part of the ventral VZ called pMN, which also generates motor neurons (reviewed by Richardson et al., 2006) .
The stages of Schwann cell and oligodendrocyte development can be delineated by the use of molecular markers that characterize the different stages of development and differentiation, including myelination (Jessen and Mirsky, 2005; Richardson, 2001) . In terrestrial vertebrates and teleost fish, cells of both Schwann cell and oligodendrocyte lineages express the HMG box protein SOX10 throughout their development and Developmental Biology 297 (2006) 1 -13 www.elsevier.com/locate/ydbio subsequent differentiation (Dutton et al., 2001; Kuhlbrodt et al., 1998; Park et al., 2002) . A transcription factor that is specifically expressed in early Schwann cell development is the winged helix protein FOXD3. In mice, FoxD3 is preferentially expressed in developing neural crest derivatives and its zebrafish homologue, foxD3, has been observed in glial cell precursors associated with PNS axonal tracts. Transgenic foxD3-GFP zebrafish have been used to follow the co-migration of myelinating glial cells and axons in the lateral line (Gilmour et al., 2002; Kelsh et al., 2000; Labosky and Kaestner, 1998) . In mammals, birds and teleost fish, oligodendrocyte precursors (OLPs) can be identified, prior to and during migration, by expression of the transcription factors Olig2 and/or Olig1 (Lu et al., 2000; Park et al., 2002; Takebayashi et al., 2000; Zhou et al., 2000) . Olig genes are required for the generation of OLPs since compound disruption of Olig1 and Olig2 results in a complete lack of oligodendrocytes throughout the CNS. Olig2 null mice or zebrafish treated with olig2-suppressing morpholino oligonucleotides show deficiencies of both motor neurons and OLPs, indicating that these two cell types share common precursors in the spinal cord and brainstem (Lu et al., 2002; Park et al., 2002; Takebayashi et al., 2002; Zhou and Anderson, 2002) .
In teleost fish, myelination in both PNS and CNS is characterized by upregulation of myelin proteins such as myelin protein zero (Mpz), myelin basic protein (Mbp), and orthologs of the DM20 isoform of proteolipid protein (Plp1a/b) (Brosamle and Halpern, 2002; Schweitzer et al., 2003 Schweitzer et al., , 2005 . The process has been well characterized in zebrafish. Upregulation of mbp, mpz and plp1b begins in a few oligodendrocytes in the hindbrain at 48 hpf. At this stage, mbp expression is also detectable in the anterior-most Schwann cells of the lateral line. However, neither plp1b nor mpz are expressed in the PNS at this stage. The number of myelin-forming oligodendrocytes and Schwann cells increases gradually and in a rostro-caudal gradient over the next few days. Axons ensheathed by loosely wrapped glial processes can be detected in the ventral hindbrain and the lateral line by 4 days post-fertilization and compact myelin is observed by 7 days in the hindbrain, lateral line and optic nerves (Brosamle and Halpern, 2002; Schweitzer et al., 2003) .
Myelin differentiation in both the CNS and PNS is regulated by interactions between Schwann cell precursors/OLPs and neurons. In rodents, neuronal β-neuregulin, signalling via Erb2 and Erb3 receptors, is required for myelination and regulates the thickness of the myelin sheath (Dong et al., 1995; Garratt et al., 2000; Meyer and Birchmeier, 1995; Michailov et al., 2004; Taveggia et al., 2005) . A recent screen for glial defects in zebrafish also implicated neuregulin signalling in Schwann cell development (Lyons et al., 2005) . Effects on oligodendrocyte differentiation are less well established in vivo, but in rodents the signalling factors retinoic acid (RA) and thyroid hormone induce cultured OLPs to stop dividing and differentiate. RA acts via a p53-dependent pathway and directly activates the Mbp promoter in these cells (Noll and Miller, 1994; Pombo et al., 1999; Tokumoto et al., 2001 ).
To discover new molecules that are potentially important in glial development and particularly in myelination, we undertook a screen of zebrafish mutants with previously characterized neural defects. We took advantage of some of the systematic mutagenesis screens that have previously been carried out in zebrafish. Early screens focussed on morphologically obvious defects in early neural development . More recent screens have searched for more subtle effects, for example on the number or identity of immunohistochemically distinct classes of neuron (Guo et al., 1999) . We screened a subset of both these types of mutant for associated defects in Schwann cell and oligodendrocyte development and differentiation during larval development, focussing particularly on Schwann cells of the posterior lateral line (PLL) nerve and oligodendrocytes in the spinal cord. We screened by in situ hybridization for defects in either temporal or spatial expression of mbp mRNA. Both Schwann cells and oligodendrocytes express mbp highly at the onset of myelination and it is easily visualized in the PLL and spinal cord (Brosamle and Halpern, 2002; Lyons et al., 2005) . Our screen of 39 mutant lines identified two loci (neckless and motionless) in which there was no mbp expression in posterior lateral line (PLL) glia, despite the presence of axons, and mbp expression was also affected in a proportion of CNS oligodendrocytes. In 2 other mutants (iguana and doc), mbp expression was restricted to the most anterior glial cells of the PLL. In all of these mutants electron microscopic (EM) analysis showed that Schwann cells were present and had begun to wrap axons but had not formed fully differentiated myelin. The neckless gene product is required for RA synthesis; we used RA inhibitors and phenotypic rescue by application of exogenous RA to show that RA signalling is required at an early stage of nervous system development, long before the onset of myelin gene expression and even before the formation of overt glial-specific precursors (Schwann cell precursors or OLPs).
Materials and methods

Tissue preparation
Zebrafish specimens (Danio rerio) in different stages of development were maintained according to standard procedures at the Zebrafish Group, Anatomy Department, University College London, UK. Embryos, larvae and juvenile specimens were collected from pair matings, raised at 28°C with a 14-h/10 h light-dark cycle. They were staged according to hours postfertilization (hpf) and morphological criteria .
To prepare sections larvae were anaesthetized with 0.3% tricaine methane sulfonate, MS22 (Sigma) and then fixed in fresh fixative overnight. To cryoprotect, tissue was transferred to 20% sucrose in PBS and left at 4°C for a further 24 h. Samples were then embedded in Tissue-Tek OCT compound (Agar Scientific Ltd., UK) and frozen slowly on dry ice. Frozen 10-15 μm sections were cut using a cryostat microtome.
Whole mount RNA in situ hybridization
Digoxeginin-labeled RNA probes were synthesized following the manufacturer's instructions (Roche Molecular Biochemicals). Whole-mount RNA in situ hybridization was performed as previously described (Thisse et al., 1993; Xu et al., 1994) .
Larvae were fixed overnight in 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS) at pH 7.5. After incubation in PBS + 0.1% Tween 20 (PBT), larvae were permeabilized by proteinase K treatment (40 μg/ml in PBT, 1 h for larvae at 5 dpf), postfixed in 4% paraformaldehyde, and washed extensively followed by incubation in hybridization mix (50% deionized formamide, 5× SSC, 0.1% Tween 20, torula RNA 5 mg/ml, heparin 50 μg/ml, pH 6.0) for 3 h at 65°C. Probe hybridization was carried out over night at 65°C. Unbound probe was removed by a series of washes. Larvae were blocked for 3 h in 2% Blocking Reagent (Roche Molecular Biochemicals) in MABT solution (Maleic acid (0.1 M), NaCl (0.15 M), pH 7.5 plus 0,1% Tween 20). Antidigoxygenin Fab fragments coupled to alkaline phosphatase (Roche Molecular Biochemicals) were used to detect hybridized probe using BM Purple AP Substrate (Roche Molecular Biochemicals). Larvae were transferred into glycerol and photographed using a Polaroid PDMC-3 camera.
The RNA probes used included mbp, plp1b, mpz and foxD3 prepared from EST clones fj45g01, fj43c04, fj33a07 and fk47f08 (Brosamle and Halpern, 2002; Kelsh et al., 2000) . Probes for sox10 (Dutton et al., 2001 ) and olig2 (Park et al., 2002) were synthesized from cloned PCR products amplified from zebrafish genomic DNA using the primer pairs 5′-ACC GTG ACA CAC TCT ACC AAG ATG ACC-3′/5′-CAT GAT AAA ATT TGC ACC CTG AAA AGG-3′ and 5′-GCT TCA TCT CCT CCA GCG AGG-3′/5′-AAA CTG AGA GCG CAC TGA ACC-3′.
Immunohistochemistry
For whole mount immunohistochemistry, larvae were fixed in 10% trichloroacetic acid (TCA) for 3 h, permeabilized in 0.25% trypsin in PBT on ice, extensively washed and stored in PBT. After blocking (1% DMSO, 10% goat serum, 0.8% Triton X-100 in PBT) for 1-3 h, antibodies for acetylated tubulin (Sigma) were applied overnight in the same solution. Antibody binding was detected using either horseradish peroxidase, fluorescein isothiocyanate (FITC) or Alexa 568 conjugated secondary antibodies. For sections embryos were fixed and prepared as for in situ hybridization. Mouse monoclonal antibody for Isl1 (Developmental Studies Hybridoma bank) was applied overnight in PBT and antibody binding detected using rhodamine conjugated anti-mouse secondary antibodies (Roche Molecular Biochemicals). Samples were examined using either a Nikon Eclipse 800 photomicroscope or a Leica confocal microscope.
Electron microscopy
For electron microscopy, larvae were fixed overnight in 6% glutaraldehyde in 0.1 M cacodylate buffer pH 7.4, washed in 0.1 M cacodylate and postfixed in 2% osmium tetroxide. After washing, larvae were incubated in 2% uranyl acetate solution for 1 h. After several rinses in water, larvae were dehydrated, followed by epoxy propane, infiltration and embedding in resin mixture (Agar scientific Ltd.). Ultrathin sections were examined in a JEOL 1010 electron microscope.
Retinoic acid and DEAB treatment
To rescue nls mutants by application of RA, eggs were incubated from tail bud stage (10 hpf ) to 16 somites (16 hpf) or from 16 somites to 24 somites (19 hpf) in E3 medium containing 0.01 M all trans RA (Sigma R2625). This medium was prepared by diluting a 10 M stock solution of all-trans RA in DMSO 1:1000 in E3. At the end of the treatment window, the embryos were rinsed several times in E3 before replacing the RA-containing medium with fish water. DEAB (4-diethylaminobenzaldehyde; Fluka) was applied at a concentration of 10 −5 M in E3 medium from a 10 −2 M stock in DMSO. Control embryos were treated for the same time periods with DMSO in E3.
Results
Screening neurological mutants for myelination defects
We screened 39 mutants with established neurological, neural crest or behavioral phenotypes for myelination defects in the PLL (Table 1) . Our rationale for this was that, given the shared developmental origins of neurons and glia and the extensive interactions required for normal myelination, mutations in many genes that affect neuronal development might also be expected to impact glial development. For the first stage of the screening process, we used in situ hybridization of whole mount embryos/larvae to identify mutants with abnormal mbp expression in the developing PLL. Mbp is the first myelin protein gene to be expressed by Schwann cells in the PLL (Brosamle and Halpern, 2002) . At 2.5-3 dpf mbp transcripts can be detected in the anterior-most glial cells of the PLL, immediately posterior to the PLL ganglion (Fig. 1A) . Mbp expression gradually spreads to more posterior glial cells and by 5 dpf can be detected throughout the PLL (Figs. 1B-D). Other PNS myelin protein genes including plp1b (Fig. 1E ) and mpz (Schweitzer et al., 2003) show a similar anterior-to-posterior sequence of activation in the PLL. We screened for mbp expression in the PLL between 3 and 5 dpf depending on mutant viability (the majority of the mutants die around 4-5 dpf). Screening late in the myelination process allowed us to detect effects on the differentiation of myelinating glia as well as the specification, proliferation and survival of their precursors.
Of the 39 mutants screened, 25 had normal mbp expression in the PLL. In 9 mutants the line of mbp expression followed an abnormal path, in 4 mutants mbp was not expressed in the PLL at all and in 2 mutants it was restricted to the anterior-most glial cells. For the second stage of the screening process we used the axonal marker acetylated tubulin to determine whether the abnormal mbp expression we had observed might simply reflect axonal abnormalities in the PLL of these mutants.
In wild type fish the PLL nerve runs along the horizontal myoseptum from the PLL ganglion to the tail (Fig. 1F) . By 4 dpf, the mechanosensory neuromasts of the PLL have migrated away from the myoseptum to slightly more ventral locations and axons can be seen branching off from the main PLL nerve bundle to maintain innervation of the neuromasts. In all 9 mutants in which mbp expression followed an abnormal path, PLL axons were found to be misrouted in the same way. We concluded that in these mutants the underlying defect was in axonal pathfinding and discarded them from the study. In all 6 mutants showing truncated/absent mbp expression in the PLL the axons were clearly present in all larvae that hatched. In these mutants, the defect in mbp expression could therefore not be accounted for by the nerve simply failing to form.
For the third and final stage of the screening process, we used electron microscopy (EM) analysis to determine whether morphologically differentiated myelinating glia were present in the PLL. In wild type fish Schwann cells begin to enwrap axons before 72 hpf (Levavasseur et al., 1998) and by 5 days multiple loose wraps can be seen by EM (Figs. 1G, H) . Differentiating Schwann cells enwrapping the PLL axons were present in all four of our mbp expression mutants.
Doc and iguana
Mutations in doc (doc) have cell-autonomous effects on notochord development and are associated with failure to Reifers et al., 1998; Trowe et al., 1996; Whitfield et al., 1996) (Heisenberg et al., , 2001 ) miles apart m93 edg5 Faint mbp expression with gaps Heart defects (Chen et al., 1996; Kupperman et al., 2000 ) mind bomb m132 RING ubiquitin ligase Normal Neurogenesis and brain defects (Itoh et al., 2003; Jiang et al., 1996; Schier et al., 1996; van Eeden et al., 1996 ) monorail v53a Normal Floorplate development (Chen et al., 1996; Norton et al., 2005 ) one eyed pinhead tz57 oep Faint mbp expression in caudal region Floorplate defects Stemple et al., 1996; Zhang et al., 1998 ) parachute cdh2 Normal Brain and eye defects Lele et al., 2002; Masai et al., 1997; Odenthal et al., 1996; Trowe et al., 1996 ) silberblick u148 wnt11 Normal Forebrain defects (Heisenberg and Nusslein-Volhard, 1997; Heisenberg et al., 1996; Piotrowski et al., 1996 ) sucker tf216b endotelin 1 Normal Jaw defects (Miller et al., 2000; Piotrowski et al., 1996 ) schmalspur m786 foxh1 Normal Brain and ventral neurectoderm defects (Chen et al., 1996; Piotrowski et al., 1996; Pogoda et al., 2000; Schier et al., 1996; Stemple et al., 1996) 
Low level mbp expression Notochord defects (Jessen et al., 2002; Stemple et al., 1996 ) bashful u13 lama1 Line deviates and loops away from myoseptum
Notochord and brain defects Schier et al., 1996; Stemple et al., 1996 ) biber tb8 Expression in multiple thin branches along course of myoseptum Severe pattern defects (Hammerschmidt et al., 1996a) dino m84 chordin Line deviates and loops away from myoseptum Ventralised embryos (Hammerschmidt et al., 1996b; Odenthal et al., 1996; Schulte-Merker et al., 1997 ) faust am36a gata 5 Expression normal up to somites 3-5 then fades and deviates from myoseptum Cardiac defects (Chen et al., 1996; Reiter et al., 1999) floating head n1 flh Line deviates and loops away from myoseptum Notochord defects Talbot et al., 1995) slow muscle omitted b641 smo Line deviates and loops away from myoseptum
Floorplate and ventral neural tube defects (Varga et al., 2001) spade tail b104 Tbx16 Line deviates and loops away from myoseptum Notochord defects (Eisen and Pike, 1991; Griffin et al., 1998; Odenthal et al., 1996) Low level mbp expression U-boot tp39 Prdm1 Line deviates and loops away from myoseptum
Neural crest and locomotion defects (Baxendale et al., 2004; ) you too ty119a Gli2 Line deviates and loops away from myoseptum Neural tube defects (Dickmeis et al., 2001; Karlstrom et al., 1996; Piotrowski et al., 1996; van Eeden et al., 1996) 
No mbp expression beyond first 5 somites
Midline defects (Chen et al., 1996; Sekimizu et al., 2004; Wolff et al., 2004 ) doc tt258 No mbp expression beyond first 5 somites Notochord and locomotion defects (Chen et al., 1996; Odenthal et al., 1996; van Eeden et al., 1996) All mutants were ENU induced with the exception of chinless (γ irradiation) and floating head (spontaneous). References to other relevant phenotypic effects (neural development, locomotion etc).
maintain expression of the zebrafish T-brachyury homologue no tail . Iguana (igu) is a member of the midline group of mutants and shows the characteristic curved body shape and defects in cell fate specification in the ventral neural tube and somites . It has been cloned and codes for a novel intracellular regulator of hedgehog signalling Dzip1 (Sekimizu et al., 2004; Wolff et al., 2004) . Doc and igu mutants show very restricted mbp expression in the PLL (Figs. 2A, B) . Even at 5 dpf mbp can only be detected in the anterior-most segments, although by this stage the PLL nerve extends almost the full length of the fish in both these mutants (Figs. 2C, D) . In doc mutants, EM analysis reveals that morphologically differentiating myelinating glial cells are still present in posterior segments, in which there is no detectable mbp (Figs. 2E, F) .
Motionless/otter
Motionless (mot) is likely to be allelic with otter (ott), a previously described mutant with ventricular defects. Mot mutants also show defects in certain classes of CNS neurons and anterior commissure formation is also severely disrupted (Guo et al., 1999) .
Mot and ott mutants die around 4 dpf and show no expression of mbp in either the PNS or the CNS at any stage (Figs. 3A, B) . We could detect no differences between the myelination phenotypes of mot and ott and further analysis has focussed exclusively on ott.
Ott mutants lack plp1b as well as mbp expression, although mpz is detectable in the CNS (Figs. 3C-E) . PLL axons are present and early markers for PNS myelinating glial cells, such as foxD3, are expressed as these cells migrate out from their origin in the PLL ganglion (Figs. 3F-J) . The nerve grows out more slowly than in the wild type and never extends the full length of the fish. Despite their lack of myelin protein gene expression, PLL glial cells in the mutants appear to begin morphological differentiation and at 80 hpf are indistinguishable from wild type glial cells in EM sections (Figs. 3K, L) .
We performed some further analysis of the CNS phenotype in ott mutants focussing on the expression of oligodendrocyte and motor neuron lineage specific markers in sections through the spinal cord. At 80 hpf no mbp or plp1b-expressing cells were present in mutant spinal cord. Occasional mpz-expressing cells were seen in the grey matter although not at the peripheral locations typical for differentiating oligodendrocytes in wild type fish (Figs. 4A-F) . Most spinal cord oligodendrocytes originate from the ventral olig2-expressing domain of the VZ that earlier gives rise to motor neurons (Park et al., 2004) . We analyzed the expression of olig2 and the early motor neuron marker Islet1 (Isl1) in ott mutants (Figs. 4G-J) . At 80 hpf, the distribution of Isl1-expressing cells appeared normal but olig2 was still restricted to the ventricular zone, whereas in wild type fish it could also be seen in the peripheral cells, which are thought to represent migrating OLPs (Park et al., 2002) . As in the PNS, EM analysis of spinal cord identified differentiating glial cells had begun to loosely wrap axons (Figs. 4K, L) .
Neckless/no fin
Both neckless (nls) and no fin (nof) mutations disrupt the zebrafish homologue of the RA synthesis enzyme Aldh1a2 (Begemann et al., 2001; Grandel et al., 2002) . This enzyme catalyzes the final step in RA synthesis from vitamin A and is expressed during early embryogenesis. In zebrafish, mutations in aldh1a2 act non-cell-autonomously to cause rhombomeres 5-7 to expand and affect the differentiation of catecholaminergic and brachiomotor neurons in the hindbrain. A recent analysis (Begemann et al., 2004) of nls mutants prior to myelinogenesis (48 hpf) showed that in a proportion (30%) of embryos, expression of the axonal marker Tag-1 in the PLL nerve was attenuated, suggesting that in these embryos the axons fail to extend past the level of the first somite. Both the size of the PLL ganglion and the thickness of the axonal bundle were reduced in all embryos. A significant fraction of mutant embryos die shortly after this stage of development.
We found that mbp expression is absent from the PLL of nls and nof mutants at 5 dpf but present at normal levels in the anterior lateral line and all other regions of the PNS and CNS (Fig. 5A) . In all mutants that survive to 5 days, the PLL nerve was present and extended the entire length of the fish. We found that at least 50% of mutant fish fail to hatch and infer that this fraction includes the 30% in which axons fail to extend (Begemann et al., 2004) . However, we observed that, although the nerve itself appeared normal in mutants that survived for 5 days, the branches that innervate individual neuromeres were abnormally short (Fig. 5B) . In contrast to the nls mutants, nof mutants displayed a variable mbp phenotype-only ∼40% (17/ 44) mutants had abnormal mbp expression in the PLL and, in ∼12% of those that did, mbp expression was normal on one side of the fish and completely absent on the other (Figs. 5C, D) . Since the nls phenotype was relatively invariant, we used this mutant for all subsequent analysis of the effects of aldh1a2 disruption on PLL development. Plp1b expression can be detected in the PLL of nls mutant fish at reduced levels compared to wild type (Figs. 5E, F) . EM analysis of 5-day-old mutants also showed cells enwrapping the axons of the PLL which were morphologically indistinguishable from wild type myelinating glia at this stage of normal development (Figs. 5G, H) . An effect on mbp expression is also seen in the spinal cord of nls mutants. We observed a complete lack of mbp expression in spinal cord oligodendrocytes in ∼85% (41/47) of 5-day-old nls larvae, although the oligodendrocyte precursor marker sox10 is expressed normally (Figs. 6A-C) . Cells with a similar morphology to wild type differentiating oligodendrocytes can be seen by EM (data not shown). A similar lack of mbp expression is seen in wild type fish treated with the RA synthesis inhibitor DEAB from 11 hpf (Fig. 6D) .
To determine the developmental stage at which RA synthesis is required for normal mbp expression in both Schwann cells of the PLL and spinal cord oligodendrocytes, we used timed application of either exogenous RA (to rescue the PLL phenotype in nls mutants) or DEAB (to suppress RA synthesis in wild type fish). In both cases, treatment had to be applied relatively early in development; no effects on mbp expression were seen in the CNS of fish to which DEAB was applied later than 26 hpf (Table 2, Figs. 6E, F) . Similarly, mbp expression was restored in the PLL of 100% of nls mutant fish to which RA was applied between 10 and 16 hpf but only in 33% of larvae treated between 16 and 19 hpf (Table 3 , Fig. 6F ).
Discussion
An advantage of zebrafish as an experimental model is the ability to conduct forward genetic screens. Screens can be performed either of newly induced mutants, bred to homozygosity following mutagenesis, or of panels of mutants that have been identified previously on the basis of some other phenotype (so-called shelf screens). Recently, at least two groups have successfully conducted de novo screens for mutations that perturb myelination and mbp expression. In one of these, a screen of 600 mutagenized genomes isolated eleven different genes affecting various stages of myelin development (Lyons et al., 2005) . We have performed a shelf screen of 39 mutants with known CNS defects, which uncovered mutations in four loci that affect mbp expression in the PLL. None of these mutants had been uncovered in the de novo screens, which focused on glial cell specific phenotypes and may have rejected mutants with pleiotropic phenotypes. The relatively high success rate of our approach suggests that screening for genes involved in both neuronal and glial development would be a useful strategy to complement de novo screening efforts. Screening for mutants that lack mbp-expressing cells, we identified four loci that affect myelin protein gene expression during the differentiation stage. Layers of myelin around some axons, indicating the presence of differentiating Schwann cells and oligodendrocytes, are present in all mutant fish. The effects of doc and igu are restricted to the posterior part of the PLL while mot and aldh1a2 have effects throughout the PLL. Mutations at mot/ott have widespread effects on neural and vascular development. All mutants die around 4 dpf, probably due to vascular defects. Previous studies show an effect on neuronal differentiation in the form of a pronounced reduction in the numbers of catecholaminergic (CA) neurons in the CNS and a failure of axon extension in those cells that do express the appropriate markers. Our observations on PLL development suggest that neural differentiation is also delayed and incomplete in the PNS. While the effects on neural differentiation are widespread, not all neurons are affected. Branchial arch-associated CA neurons and isl1-expressing motor neurons appear normal. By contrast, the effects on Schwann cell and oligodendrocyte differentiation are universal. No mbp expression can be detected in either the PNS or the CNS of mot/ott larvae. This suggests that the effects on myelination might be independent of the neuronal defects and possibly cell autonomous. A better understanding of the specific role played by this gene in myelinating glial cells will be possible when the locus has been cloned. The effects on myelination observed in nof and nls mutants are especially interesting. RA signalling has been implicated at several stages of oligodendrocyte development in higher vertebrates (Appel and Eisen, 2003) and RA has been shown to activate the Mbp promoter in rat optic nerve glial cell cultures (Pombo et al., 1999) . However, there is less evidence that RA is required in Schwann cell development although RA synthesis enzymes and receptors are expressed in peripheral nerves (Berggren et al., 1999) .
In nls mutant fish, the effects on the oligodendrocyte and Schwann cell lineages are surprisingly similar and specifically involve mbp expression as both plp1b and mpz expression can still be detected in the mutants. Given that the onset of mbp expression is a very late event in the development of myelinforming cells, our finding that the requirement for RA synthesis is restricted to early stages of PNS and CNS development is unexpected. In the PNS, the earliest time that committed glial cell precursors can be identified by FoxD3 expression is at the 15-somite stage (17 hpf) (Kelsh et al., 2000) but exogenous RA applied between tailbud (10 hpf) and 14-somites (16 hpf) is sufficient to restore mbp expression in the PLL of nls mutants (Fig. 6F) . Similarly, in the CNS, oligodendrocyte specific markers such as sox10 are first expressed around 56 hpf (Park et al., 2004) but blocking RA synthesis by DEAB treatment after 26 hpf has no effect on mbp expression in the spinal cord (Fig.  6E) . A direct effect of RA on the differentiation of myelin forming cells therefore seems very unlikely, because RA synthesis is required before the appearance of overt glialspecific precursors (Schwann cell precursors or OLPs). However, RA signalling might be required for proper development of earlier neuroglial or glial-restricted precursors, such that their ability to generate fully functional glial progeny is impaired in the mutant. As both OLPs and Schwann cell precursors divide prior to differentiation, then this interpretation implies that RA might induce some heritable change in the precursor cells that is permissive for later mbp expression. This could be an epigenetic modification affecting the mbp gene, for example. An alternative possibility is that the primary effect of RA is on neuronal development. Unlike glial cells, neurons are present in both the PNS and the CNS during the period of RA sensitivity. PLL neurons first begin to extend axons around 16 hpf and, in the CNS, primary neurons are born around 10 hpf and secondary neurons between 16 and 25 hpf (Myers et al., 1986) . Motor neuron development in the hindbrain and mbp expression in the CNS have similar windows of sensitivity to DEAB treatment between 14 and 17 hpf (Begemann et al., 2004; Linville et al., 2004) . Early exposure to RA might be required to set in train certain aspects of neuronal differentiation that are required for the later activation of myelination in Schwann cell precursors or OLPs. Further experiments will be required to determine whether neuronal defects alone are sufficient to account for the failure to activate mbp expression.
